Skip to Content

Deferasirox

In the US, Deferasirox (deferasirox systemic) is a member of the drug class chelating agents and is used to treat Hemosiderosis, Iron Overload and Thalassemia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V03AC03

CAS registry number (Chemical Abstracts Service)

0201530-41-8

Chemical Formula

C21-H15-N3-O4

Molecular Weight

373

Therapeutic Category

Iron chelator

Chemical Names

4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl}benzoesäure (IUPAC)

4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl}benzoic acid (WHO)

Foreign Names

  • Deferasiroxum (Latin)
  • Deferasirox (German)
  • Deferasirox (French)
  • Deferasirox (Spanish)

Generic Names

  • Deferasirox (OS: USAN, JAN)
  • CGP-72670 (IS: Novartis)
  • ICL 670 (IS)
  • ICL-670A (IS: Novartis)

Brand Names

  • Exjade
    Grupo Novartis, Spain; Haemato Pharm, Austria; Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, China; Novartis, Czech Republic; Novartis, Denmark; Novartis, Ecuador; Novartis, Egypt; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Japan; Novartis, South Korea; Novartis, Lebanon; Novartis, Lithuania; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis, Tunisia; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis AH, South Africa; Novartis Europharm, Austria; Novartis Europharm, Cyprus; Novartis Europharm Limited, Latvia; Novartis Farma, Italy; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland; Novartis Pharma, Russian Federation; Novartis Pharma, Vietnam; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom
  • EXJADE
    Novartis Pharma, Germany

International Drug Name Search

Glossary

TermDefinition
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide